Table 2.
Demographics of patients enrolled in DSD models
| Variable | Early enrollers of DSD models (n=6340) | Established enrollers of DSD models (n=25 857) | |
| Age in years, median (IQR) | 36 (29–44) | 37 (29–44) | |
| Age group, n (%) | 15–24 | 727 (11) | 2589 (10) |
| 25–34 | 2069 (33) | 8346 (32) | |
| 35–49 | 2658 (42) | 11 424 (44) | |
| 50+ | 885 (14) | 3487 (13) | |
| Sex, n (%) | Female | 3914 (62) | 15 666 (61) |
| Male | 2426 (38) | 10 191 (39) | |
| Location, n (%) | Rural | 2501 (39) | 9078 (35) |
| Urban | 3839 (61) | 16 779 (65) | |
| Year of ART initiation, n (%) | 2019 | 2897 (46) | 17 346 (67) |
| 2020 | 3443 (54) | 8511 (33) | |
| DSD type, n (%) | Adherence groups | 149 (2) | 508 (2) |
| Community pick-up points | 671 (11) | 1461 (6) | |
| Extended clinic hours | 85 (1) | 97 (<1) | |
| Fast-track | 979 (15) | 6266 (24) | |
| Home ART delivery | 355 (6) | 973 (4) | |
| Multimonth dispensing | 4101 (65) | 16 552 (64) | |
| ART months dispensed, n (%) | <2 | 636 (10) | 1476 (6) |
| 3 | 2197 (35) | 5688 (22) | |
| 4–6 | 3507 (55) | 18 679 (72) | |
| Outcome year, n (%) | 2020 | 2863 (45) | 17 283 (67) |
| 2021 | 3477 (55) | 8574 (33) | |
| Months on ART at outcome, median (IQR) | 17.9 (16.4–19.5) | 18.4 (16.7–19.8) | |
| On DSD at outcome, n (%) | Yes | 6340 (100) | 20 856 (81) |
| No | 0 (0) | 5001 (19) | |
| Months on DSD at outcome, median (IQR) | 14.7 (13.0–16.5) | 5.8 (2.9–8.9) | |
| Patient outcomes by 18 months after ART initiation, n (%) | On treatment | 6133 (97) | 24 646 (95) |
| Died | 11 (<1) | 31 (<1) | |
| Lost to follow-up | 192 (3) | 1169 (5) | |
| Stopped ART | 4 (<1) | 10 (<1) | |
| Stopped DSD | 0 (0) | 1 (<1) | |
ART, antiretroviral therapy; DSD, differentiated service delivery.